Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.9B | 16.7B | 13.0B | 11.8B |
Cost of revenue | 6.1B | 10.5B | 8.0B | 7.1B |
Gross profit | 3.7B | 6.3B | 5.0B | 4.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 646.7M | 1.3B | 1.0B | 965.4M |
Operating income | 1.7B | 3.5B | 2.7B | 2.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 39K | 49K | 51K | 64K |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 3.5B | 2.7B | 2.2B |
Tax provision | 534.2M | 1.1B | 796.8M | 645.1M |
Net income | 1.2B | 2.4B | 1.9B | 1.6B |
Basic EPS | — | 1.2 | 0.9 | 0.8 |
Diluted EPS | — | 1.2 | 0.9 | 0.8 |
Basic average shares | — | 2.0B | 2.0B | 2.0B |
Diluted average shares | — | 2.0B | 2.0B | 2.0B |
EBITDA | 2.6B | 4.3B | 3.4B | 3.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |